JP2024502670A5 - - Google Patents
Info
- Publication number
- JP2024502670A5 JP2024502670A5 JP2023542963A JP2023542963A JP2024502670A5 JP 2024502670 A5 JP2024502670 A5 JP 2024502670A5 JP 2023542963 A JP2023542963 A JP 2023542963A JP 2023542963 A JP2023542963 A JP 2023542963A JP 2024502670 A5 JP2024502670 A5 JP 2024502670A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110065290 | 2021-01-18 | ||
| CN202110065290.8 | 2021-01-18 | ||
| PCT/CN2022/072265 WO2022152285A1 (zh) | 2021-01-18 | 2022-01-17 | Garp蛋白抗体及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024502670A JP2024502670A (ja) | 2024-01-22 |
| JPWO2022152285A5 JPWO2022152285A5 (https=) | 2025-01-27 |
| JP2024502670A5 true JP2024502670A5 (https=) | 2025-01-27 |
Family
ID=82446943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542963A Pending JP2024502670A (ja) | 2021-01-18 | 2022-01-17 | Ｇａｒｐタンパク質抗体及びその適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240117034A1 (https=) |
| EP (1) | EP4279509A4 (https=) |
| JP (1) | JP2024502670A (https=) |
| KR (1) | KR20230169936A (https=) |
| CN (1) | CN116710125A (https=) |
| AU (1) | AU2022207029A1 (https=) |
| BR (1) | BR112023014319A2 (https=) |
| CA (1) | CA3208624A1 (https=) |
| IL (1) | IL304453A (https=) |
| TW (1) | TW202241955A (https=) |
| WO (1) | WO2022152285A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240042020A1 (en) * | 2022-07-29 | 2024-02-08 | Abbvie Biotherapeutics Inc. | Anti-garp-tgf-beta1/pd-1 combination therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| WO2015015003A1 (en) * | 2013-08-01 | 2015-02-05 | Université Catholique de Louvain | Anti-garp protein and uses thereof |
| WO2016125017A1 (en) * | 2015-02-03 | 2016-08-11 | Universite Catholique De Louvain | Anti-garp protein and uses thereof |
| TWI909341B (zh) * | 2015-09-24 | 2025-12-21 | 日商第一三共股份有限公司 | 抗garp抗體及其製造方法及用途 |
| WO2017156500A1 (en) * | 2016-03-11 | 2017-09-14 | Scholar Rock, Inc. | Tgfb1-binding immunoglobulins and use thereof |
| US20190292254A1 (en) * | 2016-07-14 | 2019-09-26 | Scholar Rock, Inc. | TGFBeta Antibodies, Methods and Uses |
| GB201707561D0 (en) * | 2017-05-11 | 2017-06-28 | Argenx Bvba | GARP-TGF-beta antibodies |
| WO2021231732A1 (en) * | 2020-05-15 | 2021-11-18 | Bristol-Myers Squibb Company | Antibodies to garp |
-
2022
- 2022-01-17 CA CA3208624A patent/CA3208624A1/en active Pending
- 2022-01-17 CN CN202280010421.5A patent/CN116710125A/zh active Pending
- 2022-01-17 EP EP22739160.4A patent/EP4279509A4/en active Pending
- 2022-01-17 BR BR112023014319A patent/BR112023014319A2/pt unknown
- 2022-01-17 TW TW111101854A patent/TW202241955A/zh unknown
- 2022-01-17 US US18/272,826 patent/US20240117034A1/en active Pending
- 2022-01-17 JP JP2023542963A patent/JP2024502670A/ja active Pending
- 2022-01-17 KR KR1020237027472A patent/KR20230169936A/ko active Pending
- 2022-01-17 AU AU2022207029A patent/AU2022207029A1/en active Pending
- 2022-01-17 WO PCT/CN2022/072265 patent/WO2022152285A1/zh not_active Ceased
-
2023
- 2023-07-13 IL IL304453A patent/IL304453A/en unknown